fashion -WSS

fashion

author：hotspot 2025-09-28 20:44:17 - browse：71

health system simulate simulation — Adobe

Venture firms, convinced they’re jumpstarting the world’s most helpful tech products, have struggled mightily to get them in the hands of cash-strapped, risk-averse hospital administrators and clinicians — but that could change as tech startups and their powerful backers explore ever closer relationships with health care providers.

Among them is General Catalyst, which on Sunday announced a health business spinout with plans to buy a health system of its very own. The new business, called the Health Assurance Transformation Corporation or HATCo, is on the lookout for health systems to purchase. The idea is to create a testing ground for new tech that could improve patients’ health while making hospital processes more efficient. General Catalyst — which has backed household names like Airbnb and Warby Parker well before they were successful companies — did not say how much they’d invest to acquire a health system.

It’s the most overt attempt by a venture firm to directly shape how hospitals use technology to provide care. General Catalyst already works closely with a network of 15 health systems across 43 states eager for early access to technology developed by its portfolio companies and companies it has launched — including IT software developers like Commure — but has so far operated as more of a partner to health systems than an owner.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Designating disabled people as health disparity population is crucial

WSS

Bird flu: Don't repeat Covid's 'health versus the economy' framing

HHS names first

JPM 2024: Nvidia claims we're in biological revolution. Are we?

Solving academic medical centers' existential crisis

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

GSK to buy asthma

focus

fashion

knowledge

Walensky prepares to leave CDC — and Congress — behind

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

Duchenne breakthrough therapy leaves behind pioneering families

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

DIEP, the 'gold standard' of breast reconstruction, is under threat

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Second House panel advances two

What does generative AI mean for health care? We asked experts

Readers respond to H5N1 and livestock movements, and more

knowledge

Venture capitalist Bob Kocher on the state of digital health

Second House panel advances two

NVIDIA and Google execs on the future of AI and drug discovery

Idaho abortion case may prompt more restrictions in other states

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

focus

hotspot

focus

focus